Recent advances in peptide-based therapy for Type 2 diabetes and obesity

J. Michael Conlon; Peter R. Flatt; Clifford J. Bailey

doi:10.1016/j.peptides.2021.170652

Recent advances in peptide-based therapy for Type 2 diabetes and obesity

J. Michael Conlon^*, Peter R. Flatt, Clifford J. Bailey

^*Corresponding author for this work

College of Health and Life Sciences

Research output: Contribution to journal › Editorial › peer-review

Abstract

The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

Original language	English
Article number	170652
Journal	Peptides
Volume	145
Early online date	20 Sept 2021
DOIs	https://doi.org/10.1016/j.peptides.2021.170652
Publication status	Published - Nov 2021

Bibliographical note

Access to Document

10.1016/j.peptides.2021.170652

peptide-based therapy for Type 2 diabetes
© 2021, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
Accepted author manuscript, 660 KBLicence: CC BY-NC-ND 3.0

Cite this

@article{f69adeaf984f4c8db65607af49ccee49,

title = "Recent advances in peptide-based therapy for Type 2 diabetes and obesity",

abstract = "The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.",

author = "Conlon, {J. Michael} and Flatt, {Peter R.} and Bailey, {Clifford J.}",

note = "{\textcopyright} 2021, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/",

year = "2021",

month = nov,

doi = "10.1016/j.peptides.2021.170652",

language = "English",

volume = "145",

journal = "Peptides",

issn = "0196-9781",

publisher = "Elsevier",

}

TY - JOUR

T1 - Recent advances in peptide-based therapy for Type 2 diabetes and obesity

AU - Conlon, J. Michael

AU - Flatt, Peter R.

AU - Bailey, Clifford J.

PY - 2021/11

Y1 - 2021/11

N2 - The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

AB - The incidence of obesity-related Type 2 diabetes mellitus (T2DM) continues to increase worldwide at an alarming rate. This editorial attempts to highlight some recent developments in the therapeutic applications of peptides for the control of glucose homeostasis and reduction in body weight in these patients.

UR - https://linkinghub.elsevier.com/retrieve/pii/S0196978121001601

U2 - 10.1016/j.peptides.2021.170652

DO - 10.1016/j.peptides.2021.170652

M3 - Editorial

SN - 0196-9781

VL - 145

JO - Peptides

JF - Peptides

M1 - 170652

ER -

Recent advances in peptide-based therapy for Type 2 diabetes and obesity

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this